Atlas Trials

A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma

Clinical trial NCT01063907 · COMPLETED

Trial details

NCT number
NCT01063907
Sponsor
Kyowa Kirin Co., Ltd.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2010-03-01
Primary completion
2013-11-01
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.